Article date: February 1980
By: HELEN LABURN, D. MITCHELL, J. STEPHEN in Volume 71, Issue 2, pages 525-528
We injected the potent prostaglandin synthesis inhibitors, floctafenine and indomethacin, intravenously and intracerebroventricularly in rabbits made febrile by intravenous injection of leucocyte pyrogen.
Floctafenine (75 μmol) injected intravenously failed to affect the fever, whereas indomethacin (15 μmol) markedly reduced the fever.
When injected into the cerebral ventricles, floctafenine was feebly antipyretic, and then only at a dose ten times the antipyretic dose of indomethacin.
Our results support the suggestion that floctafenine has no antipyretic action when administered peripherally. However, its lack of antipyretic effect cannot be explained solely on the grounds that it fails to cross the blood‐brain barrier.
We injected the potent prostaglandin synthesis inhibitors, floctafenine and indomethacin, intravenously and intracerebroventricularly in rabbits made febrile by intravenous injection of leucocyte pyrogen.
Floctafenine (75 μmol) injected intravenously failed to affect the fever, whereas indomethacin (15 μmol) markedly reduced the fever.
When injected into the cerebral ventricles, floctafenine was feebly antipyretic, and then only at a dose ten times the antipyretic dose of indomethacin.
Our results support the suggestion that floctafenine has no antipyretic action when administered peripherally. However, its lack of antipyretic effect cannot be explained solely on the grounds that it fails to cross the blood‐brain barrier.
DOI: 10.1111/j.1476-5381.1980.tb10967.x
View this article